The Advancing Research for Chronic Pain Act (S. 5041) is a bipartisan bill introduced in the U.S. Senate on July 21, 2026. It aims to improve and standardize data collection on chronic pain by directing the Centers for Disease Control and Prevention (CDC) to analyze and publish comprehensive population health data on chronic pain. This initiative seeks to identify trends, risks, and consequences associated with chronic pain, thereby informing interventions to enhance care, improve patient outcomes, and reduce related costs.
The U.S. Pain Foundation has expressed strong support for the bill, highlighting its potential to provide high-quality data necessary for better understanding and treating chronic pain. They emphasize that the legislation could significantly improve the lives of millions of Americans living with chronic pain by informing more effective interventions and policies.
While specific negative media coverage is not readily available, potential criticisms of the bill could include concerns about the allocation of federal resources, the effectiveness of data collection in leading to tangible improvements in patient care, and the potential for bureaucratic inefficiencies in implementing the proposed measures.
While there are no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries, the lobbying activity in the area of chronic pain research raises some concerns. Notably, CorMedix Inc., which has contributed $220,000, is involved in pharmaceuticals that could be directly impacted by legislation related to chronic pain. The presence of significant lobbying from this company suggests a vested interest in the outcomes of this bill. Additionally, the American Library Association's lobbying, although smaller at $10,860, indicates a broader interest in research funding that could intersect with chronic pain studies. Voters should be aware that while direct conflicts are not evident, the financial influence of these entities could shape the bill's direction.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| CORMEDIX INC. | CORMEDIX INC. | $220,000 |
| BATTELLE MEMORIAL INSTITUTE | BATTELLE MEMORIAL INSTITUTE | $180,000 |
| TELECOMMUNICATIONS INDUSTRY ASSOCIATION | TELECOMMUNICATIONS INDUSTRY ASSOCIATION | $70,000 |
| TERRANOVA INC | FRONTERA GROUP | $30,000 |
| POSEIDON AEROSPACE | FRONTERA GROUP | $30,000 |
| OBSIDIA SEMICONDUCTORS | FRONTERA GROUP | $20,000 |
| SAALEX CORPORATION | FRONTERA GROUP | $20,000 |
| HERTHA METALS | FRONTERA GROUP | $15,000 |
| MN8 ENERGY LLC | MN8 ENERGY LLC | $15,000 |
| AMERICAN LIBRARY ASSOCIATION | A LEARNED HAND, LLC | $10,860 |
| RISK AND INSURANCE MANAGEMENT SOCIETY | MCINTYRE & LEMON, PLLC | $10,000 |
| VERMONT CAPTIVE INSURANCE ASSOCIATION | MCINTYRE & LEMON, PLLC | $8,000 |
| AMERICAN TRAILER MANUFACTURERS COALITION | WILEY REIN LLP | undisclosed |
| UNCAC COALITION | UNCAC COALITION | undisclosed |
| CFA INSTITUTE | CFA INSTITUTE | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Timothy Kaine, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
